drugset
drugset / Trial / NCT00833183

Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne

NCT00833183 ↗

Phase 2 Completed 44 enrolled Photocure
RandomizedParallel-groupSingle-blindTreatment

Summary

A study of safety and efficacy of topical methyaminlevulinate 80mg/g with and without occlusion followed by red light exposure in subjects with facial acne.

Timeline

Start
2007-07
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator methyl aminolevulinate Small molecule 80 unknown Topical

Indications

acne